Cargando…

Remdesivir for the Treatment of Covid-19 — Final Report

BACKGROUND: Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious. METHODS: We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beigel, John H., Tomashek, Kay M., Dodd, Lori E., Mehta, Aneesh K., Zingman, Barry S., Kalil, Andre C., Hohmann, Elizabeth, Chu, Helen Y., Luetkemeyer, Annie, Kline, Susan, Lopez de Castilla, Diego, Finberg, Robert W., Dierberg, Kerry, Tapson, Victor, Hsieh, Lanny, Patterson, Thomas F., Paredes, Roger, Sweeney, Daniel A., Short, William R., Touloumi, Giota, Lye, David Chien, Ohmagari, Norio, Oh, Myoung-don, Ruiz-Palacios, Guillermo M., Benfield, Thomas, Fätkenheuer, Gerd, Kortepeter, Mark G., Atmar, Robert L., Creech, C. Buddy, Lundgren, Jens, Babiker, Abdel G., Pett, Sarah, Neaton, James D., Burgess, Timothy H., Bonnett, Tyler, Green, Michelle, Makowski, Mat, Osinusi, Anu, Nayak, Seema, Lane, H. Clifford
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262788/ https://www.ncbi.nlm.nih.gov/pubmed/32445440 http://dx.doi.org/10.1056/NEJMoa2007764

Ejemplares similares

Marburg virus disease: A summary for clinicians
por: Kortepeter, Mark G., et al.
Publicado: (2020)

HIV continuum of care: expanding scope beyond a cross-sectional view to include time analysis: a systematic review
por: Vourli, Georgia, et al.
Publicado: (2021)

Could the 2010 HIV outbreak in Athens, Greece have been prevented? A mathematical modeling study
por: Gountas, Ilias, et al.
Publicado: (2021)

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
por: Davey, Richard T, et al.
Publicado: (2019)

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
por: Kalil, Andre C., et al.
Publicado: (2020)

Performance of TEM-PCR vs. Culture for Bacterial Identification in Pediatric Musculoskeletal Infections
por: Wood, James, et al.
Publicado: (2017)

Practice Patterns of Providers for the Management ofStaphylococcus aureus Bacteremia in Children: Results of an Emerging Infections Network Survey
por: Wood, James B, et al.
Publicado: (2018)

The Effect of HIV Treatment Interruption on Subsequent Immunological Response
por: Thomadakis, Christos, et al.
Publicado: (2023)

When to start antiretroviral therapy: the need for an evidence base during early HIV infection
por: Lundgren, Jens D, et al.
Publicado: (2013)

994. AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures in Peripheral Blood Mononuclear Cells
por: Howard, Leigh, et al.
Publicado: (2018)

Living in Roma Settlements in Greece: Self-Perceived Health Status, Chronic Diseases and Associated Social Determinants of Health
por: Petraki, Ioanna, et al.
Publicado: (2021)

A randomized trial comparing concise and standard consent forms in the START trial
por: Grady, Christine, et al.
Publicado: (2017)

Towards standardized definitions for monitoring the continuum of HIV care in Europe
por: Gourlay, Annabelle J., et al.
Publicado: (2017)

Psychotic (delusional) depression and completed suicide: a systematic review and meta-analysis
por: Gournellis, Rossetos, et al.
Publicado: (2018)

Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2
por: Fintzi, Jonathan, et al.
Publicado: (2022)

Performance of TEM-PCR vs Culture for Bacterial Identification in Pediatric Musculoskeletal Infections
por: Wood, James B, et al.
Publicado: (2018)

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial
por: Kalil, Andre C, et al.
Publicado: (2021)

Acute Effects of Ambient Particulate Matter on Mortality in Europe and North America: Results from the APHENA Study
por: Samoli, Evangelia, et al.
Publicado: (2008)

Thyroid dysfunction in Greece: Results from the national health examination survey EMENO
por: Voulgari, Paraskevi V., et al.
Publicado: (2022)

Designing Medical Facilities to Care for Patients with Highly Hazardous Communicable Diseases
por: Kortepeter, Mark G., et al.
Publicado: (2018)

Comparison of an ordinal endpoint to time-to-event, longitudinal, and binary endpoints for use in evaluating treatments for severe influenza requiring hospitalization
por: Peterson, Ross L., et al.
Publicado: (2019)

2280. Antibiotic Exposure Does Not Impact Serological Responses to Rotavirus Vaccination
por: Anderson, Evan J, et al.
Publicado: (2018)

Warp Speed for Coronavirus Disease 2019 (COVID-19) Vaccines: Why Are Children Stuck in Neutral?
por: Anderson, Evan J, et al.
Publicado: (2020)

Substantial Heterogeneity in Progress Toward Reaching the 90-90-90 HIV Target in the WHO European Region
por: Porter, Kholoud, et al.
Publicado: (2018)

Metabolite profiles associated with disease progression in influenza infection
por: Wendt, Chris H., et al.
Publicado: (2021)

Lymph node hemophagocytosis in rickettsial diseases: a pathogenetic role for CD8 T lymphocytes in human monocytic ehrlichiosis (HME)?
por: Dierberg, Kerry L, et al.
Publicado: (2006)

Short-Term Effects of Carbon Monoxide on Mortality: An Analysis within the APHEA Project
por: Samoli, Evangelia, et al.
Publicado: (2007)

The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment
por: Pantazis, Nikos, et al.
Publicado: (2016)

Antiviral Therapy (Non-HIV)
por: Beigel, John H.
Publicado: (2012)

What is the role of remdesivir in patients with COVID-19?
por: Beigel, John H.
Publicado: (2021)

Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant
por: Chen, Wilbur H., et al.
Publicado: (2014)

Prevalence of tobacco smoking and association with other unhealthy lifestyle risk factors in the general population of Greece: Results from the EMENO study
por: Gangadi, Maria, et al.
Publicado: (2021)

Disabling Dactylitis and Tenosynovitis Due to Mycobacterium haemophilum in a Patient With Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome
por: Woodworth, Michael H, et al.
Publicado: (2017)

Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV‐1 positive patients with well‐estimated dates of seroconversion
por: Stirrup, OT, et al.
Publicado: (2017)

Sensitive Assessment of the Virologic Outcomes of Stopping and Restarting Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy
por: Geretti, Anna Maria, et al.
Publicado: (2013)

Hepatitis B, C and human immunodeficiency virus knowledge among the general greek population: results from the Hprolipsis nationwide survey
por: Kaskafetou, Sylvia, et al.
Publicado: (2022)

Potential biological weapons threats.
por: Kortepeter, M G, et al.
Publicado: (1999)

A Brief History of Biocontainment
por: Cieslak, Theodore J, et al.
Publicado: (2016)

Emerging Infectious Diseases and Antimicrobial Resistance (EIDAR)
por: Lanteri, Charlotte, et al.
Publicado: (2019)

Use of a real-time risk-prediction model to identify pediatric patients at risk for thromboembolic events: study protocol for the Children’s Likelihood Of Thrombosis (CLOT) trial
por: Walker, Shannon C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sf5ds400ea1fat70p89onm00ca